Code

How digital will redefine doctor engagement in the ‘new normal’ COVID-19: What is next and beyond?

In this webcast, senior EY professionals discuss the future roadmap for pharmaceutical industry in the wake of Covid-19.

Related topics Life Sciences Digital Health

The panellists will specifically cover:

  • Path to recovery in Indian pharmaceutical sector and learnings so far
  • How can companies respond to the new normal?
  • Focus area – digital pervasiveness in doctors, patients and salesforce in the new normal

EY panellists

  • Sriram Shrinivasan - Partner and National Life Sciences Leader – EY India
  • Pramod Sudhindra - Partner, Digital Transformation (Pharma) – EY India
  • Neha Sharma - Partner, People Advisory Services – EY India

Webcast

Time your local time